Related references
Note: Only part of the references are listed.Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers
Frank Richard et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Regulation of GATA1 levels in erythropoiesis
Laura Gutierrez et al.
IUBMB LIFE (2020)
Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3
Chia-Yu Wang et al.
BLOOD (2020)
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Joao Arezes et al.
BLOOD (2020)
Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice
Eleonore Kaphan et al.
BLOOD REVIEWS (2020)
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia
Vania Manolova et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?
George J. Kontoghiorghes
EXPERT REVIEW OF HEMATOLOGY (2020)
Mitochondria Biogenesis Modulates Iron-Sulfur Cluster Synthesis to Increase Cellular Iron Uptake
Ping La et al.
DNA AND CELL BIOLOGY (2020)
Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability
Pedro A. Martinez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Inherited iron overload disorders
Alberto Piperno et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases
Maha F. Yacoub et al.
ANEMIA (2020)
Transferrin and transferrin receptors update
Hiroshi Kawabata
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Oxidative stress in chronic kidney disease
Kristien Daenen et al.
PEDIATRIC NEPHROLOGY (2019)
Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease
Matthew Sheetz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
Jing Liu et al.
HAEMATOLOGICA (2019)
Genetic loss of Tmprss6 alters terminal erythroid differentiation in a mouse model of β-thalassemia intermedia
David B. Stagg et al.
HAEMATOLOGICA (2019)
Transferrin Saturation Inversely Correlates with Platelet Function
Cristina Barale et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells
Hirokazu Tanaka et al.
CELLS (2019)
Identification and transcriptome analysis of erythroblastic island macrophages
Wei Li et al.
BLOOD (2019)
Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia
Amaliris Guerra et al.
BLOOD (2019)
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review
Xiaomu Kong et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome
Sabrina Bondu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major
Arwa Khaled et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice
Juliana Xavier-Ferrucio et al.
BLOOD (2019)
Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis
Nermi L. Parrow et al.
BLOOD (2019)
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub et al.
BLOOD (2019)
Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11
Jill M. Goldstein et al.
BLOOD (2019)
Anemia of Inflammation
Tomas Ganz
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hepcidin and Anemia: A Tight Relationship
Alessia Pagani et al.
FRONTIERS IN PHYSIOLOGY (2019)
Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia
Stefano Rivella
BLOOD (2019)
Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load
Carine Fillebeen et al.
BLOOD (2019)
Role of Mitochondria in Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2019)
SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1
Sandro Altamura et al.
HEMASPHERE (2019)
Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice
Nadine Keleku-Lukwete et al.
BLOOD ADVANCES (2019)
Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes
Frederic Picou et al.
BLOOD ADVANCES (2019)
Nrf2 controls iron homoeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin
Pei Jin Lim et al.
NATURE METABOLISM (2019)
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes
Francois Beliveau et al.
CELL CHEMICAL BIOLOGY (2019)
Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of beta-thalassemia intermedia and major
Carla Casu et al.
HAEMATOLOGICA (2018)
Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
Shadi Khalil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of beta-thalassemia intermedia and major
Carla Casu et al.
HAEMATOLOGICA (2018)
What can we learn from ineffective erythropoiesis in thalassemia?
Paraskevi Rea Oikonomidou et al.
BLOOD REVIEWS (2018)
A storm in the niche: Iron, oxidative stress and haemopoiesis
Federica Pilo et al.
BLOOD REVIEWS (2018)
Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey
Andreas M. Hohlbaum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML
Delfim Duarte et al.
CELL STEM CELL (2018)
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
Xin Jin et al.
HAEMATOLOGICA (2018)
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
Xin Jin et al.
HAEMATOLOGICA (2018)
Haemochromatosis
Pierre Brissot et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Erythroferrone inhibits the induction of hepcidin by BMP6
Joao Arezes et al.
BLOOD (2018)
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study
Ali T. Taher et al.
BLOOD (2018)
Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice
Susanna Canali et al.
BLOOD (2017)
Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma
J. Bordini et al.
LEUKEMIA (2017)
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
Addolorata Corrado et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2017)
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis
Ruben A. Mesa et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
Saroj Vadhan-Raj et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Dietary iron loading negatively affects liver mitochondrial function
Chiara Volani et al.
METALLOMICS (2017)
NRF2 Activation Impairs Quiescence and Bone Marrow Reconstitution Capacity of Hematopoietic Stem Cells
Shohei Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
Nan Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells
Yoshiharu Muto et al.
NATURE COMMUNICATIONS (2017)
Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
Tiago L. Duarte et al.
REDOX BIOLOGY (2017)
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff et al.
BLOOD (2017)
A Red Carpet for Iron Metabolism
Martina U. Muckenthaler et al.
CELL (2017)
Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera
Carla Casu et al.
BLOOD (2016)
Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
M. Boyce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
Suzana Kovac et al.
HAEMATOLOGICA (2016)
Iron Homeostasis in Health and Disease
Raffaella Gozzelino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Ferritins: furnishing proteins with iron
Justin M. Bradley et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2016)
Distinct bone marrow blood vessels differentially regulate haematopoiesis
Tomer Itkin et al.
NATURE (2016)
NCOA4 Deficiency Impairs Systemic Iron Homeostasis
Roberto Bellelli et al.
CELL REPORTS (2016)
Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels
Suzana Kovac et al.
HAEMATOLOGICA (2016)
Iron Overload and Platelet Function Defects: Possible Correlation
Abdulkader A. Dahi et al.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2016)
Oxidative stress, redox regulation and diseases of cellular differentiation
Zhi-Wei Ye et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload
Viola M. Popov et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
Tiziana Tataranni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats
Terrance D. Barrett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis
Supak Jenkitkasemwong et al.
CELL METABOLISM (2015)
Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis
Alan C. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart
Wenjing Xu et al.
CELL REPORTS (2015)
Metabolic Catastrophe in Mice Lacking Transferrin Receptor in Muscle
Tomasa Barrientos et al.
EBIOMEDICINE (2015)
The second transferrin receptor regulates red blood cell production in mice
Antonella Nai et al.
BLOOD (2015)
Myelodysplasia is in the niche: novel concepts and emerging therapies
E. Bulycheva et al.
LEUKEMIA (2015)
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
Xiao Chai et al.
SCIENTIFIC REPORTS (2015)
The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents
Yan Yu et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
Reactive Oxygen Species Regulate Hematopoietic Stem Cell Self-Renewal, Migration and Development, As Well As Their Bone Marrow Microenvironment
Aya Ludin et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo
Maura Poli et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus
Sara Gardenghi et al.
BLOOD (2014)
Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia
Rajasekhar N. V. S. Suragani et al.
BLOOD (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Keap1-Nrf2 system regulates cell fate determination of hematopoietic stem cells
Shohei Murakami et al.
GENES TO CELLS (2014)
NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation
Jung-Hyun Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Transcription factor NRF2 protects mice against dietary iron- induced liver injury by preventing hepatocytic cell death
Sandro Silva-Gomes et al.
JOURNAL OF HEPATOLOGY (2014)
HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia
Jean-Benoit Arlet et al.
NATURE (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Paul J. Schmidt et al.
BLOOD (2013)
Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients
Wenyi Lu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Iron increases the susceptibility of multiple myeloma cells to bortezomib
Alessandro Campanella et al.
HAEMATOLOGICA (2013)
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Shuling Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Nrf2 regulates haematopoietic stem cell function
Jennifer J. Tsai et al.
NATURE CELL BIOLOGY (2013)
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
Pedro Ramos et al.
NATURE MEDICINE (2013)
Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis
John D. Isaacs et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Erythropoietin
H. Franklin Bunn
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Diagnosis and treatment of hereditary hemochromatosis: an update
Pushpjeet Kanwar et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Non-transferrin bound iron: A key role in iron overload and iron toxicity
Pierre Brissot et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Physiologic implications of metal-ion transport by ZIP14 and ZIP8
Supak Jenkitkasemwong et al.
BIOMETALS (2012)
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Emilio Ramos et al.
BLOOD (2012)
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia
Stefano Rivella
BLOOD REVIEWS (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Iron levels found in hemochromatosis patients inhibit γ-thrombin-induced platelet aggregation
Stephen Lynch et al.
PLATELETS (2012)
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Igor Theurl et al.
BLOOD (2011)
The redox-sensitive transcription factor Nrf2 regulates murine hematopoietic stem cell survival independently of ROS levels
Akil A. Merchant et al.
BLOOD (2011)
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis
Hana Forejtnikova et al.
BLOOD (2010)
AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species
Marisa M. Juntilla et al.
BLOOD (2010)
Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
Barbra J. Sasu et al.
BLOOD (2010)
Cause of Death in Patients With Lower-Risk Myelodysplastic Syndrome
Farshid Dayyani et al.
CANCER (2010)
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis
Pradyumna Phatak et al.
HEPATOLOGY (2010)
Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB
Dianne Sako et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Sara Gardenghi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transferrin therapy ameliorates disease in β-thalassemic mice
Huihui Li et al.
NATURE MEDICINE (2010)
Interaction of the Hereditary Hemochromatosis Protein HFE with Transferrin Receptor 2 Is Required for Transferrin-Induced Hepcidin Expression
Junwei Gao et al.
CELL METABOLISM (2009)
Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD
Guillem Casanovas et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Delphine Meynard et al.
NATURE GENETICS (2009)
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Billy Andriopoulos et al.
NATURE GENETICS (2009)
Iron Sequestration and Anemia of Inflammation
Tomas Ganz et al.
SEMINARS IN HEMATOLOGY (2009)
Iron overload and toxicity: the hidden risk of multiple blood transfusions
A. Shander et al.
VOX SANGUINIS (2009)
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
Yin Xia et al.
BLOOD (2008)
Erythroblastic islands: niches for erythropoiesis
Joel Anne Chasis et al.
BLOOD (2008)
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression
Paul J. Schmidt et al.
CELL METABOLISM (2008)
The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
Laura Silvestri et al.
CELL METABOLISM (2008)
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells
Wan Seok Yang et al.
CHEMISTRY & BIOLOGY (2008)
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Karin E. Finberg et al.
NATURE GENETICS (2008)
A heme export protein is required for red blood cell differentiation and iron homeostasis
Sioban B. Keel et al.
SCIENCE (2008)
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
M. Cazzola et al.
Hematology-American Society of Hematology Education Program (2008)
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
Yoon-Young Jang et al.
BLOOD (2007)
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation
Dimitrios P. Kontoyiannis et al.
CANCER (2007)
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Jodie L. Babitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
Philippe Armand et al.
BLOOD (2007)
A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence
Sean C. Gifford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients
MH Miceli et al.
BONE MARROW TRANSPLANTATION (2006)
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
JL Babitt et al.
NATURE GENETICS (2006)
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
K Ito et al.
NATURE MEDICINE (2006)
Turning cells red: signal transduction mediated by erythropoietin
TD Richmond et al.
TRENDS IN CELL BIOLOGY (2005)
Iron and infection: the heart of the matter
JJ Bullen et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Iron and microbial infection
ME Schaible et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice
T Rangasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
C Lanzara et al.
BLOOD (2004)
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells
K Ito et al.
NATURE (2004)
Human platelets express hemochromatosis protein (HFE) and transferrin receptor 2
J Hannuksela et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
A Roetto et al.
NATURE GENETICS (2003)
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis
RE Fleming et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The Haber-Weiss cycle - 70 years later: an alternative view
SI Liochev et al.
REDOX REPORT (2002)
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice
G Nicolas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
CH Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An iron-regulated ferric reductase associated with the absorption of dietary iron
AT McKie et al.
SCIENCE (2001)
Ineffective erythropoiesis in β-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage
LA Mathias et al.
EXPERIMENTAL HEMATOLOGY (2000)
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
C Camaschella et al.
NATURE GENETICS (2000)
Share Paper
